Cargando…
PGC-1α overexpression is not sufficient to mitigate cancer cachexia in either male or female mice
Cancer cachexia (CC) accounts for 20%–40% of cancer-related deaths. Mitochondrial aberrations have been shown to precede muscle atrophy in different atrophy models, including cancer. Therefore, this study investigated potential protection from the cachectic phenotype through overexpression of peroxi...
Autores principales: | Morena da Silva, Francielly, Rosa-Caldwell, Megan E., Schrems, Eleanor R., Martinez, Lauren, Amos, Madeline G., Lim, Seongkyun, Cabrera, Ana Regina, Brown, Jacob L., Washington, Tyrone A., Greene, Nicholas P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201462/ https://www.ncbi.nlm.nih.gov/pubmed/35700525 http://dx.doi.org/10.1139/apnm-2022-0086 |
Ejemplares similares
-
The time-course of cancer cachexia onset reveals biphasic transcriptional disruptions in female skeletal muscle distinct from males
por: Morena da Silva, Francielly, et al.
Publicado: (2023) -
Leucine Supplementation Exacerbates Morbidity in Male but Not Female Mice with Colorectal Cancer-Induced Cachexia
por: Schrems, Eleanor R., et al.
Publicado: (2023) -
Effects of PGC-1α overexpression on the myogenic response during skeletal muscle regeneration
por: Washington, Tyrone A., et al.
Publicado: (2022) -
Development and progression of cancer cachexia: Perspectives from bench to bedside
por: Lim, Seongkyun, et al.
Publicado: (2020) -
Comparative plasma proteomics in muscle atrophy during cancer‐cachexia and disuse: The search for atrokines
por: Lim, Seongkyun, et al.
Publicado: (2020)